NCT05139121: An ongoing trial by Mylan Technologies Inc.
This trial is ongoing. It must report results 1 month from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05139121 |
|---|---|
| Title | A Phase 3, Multicenter, Open-Label, Single Arm Study of MR-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 26, 2021 |
| Completion date | Jan. 15, 2025 |
| Required reporting date | Jan. 15, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |